DHL Express delivers US donation of Pfizer-BioNTech vaccines to Malaysia

Additional one million doses contributed by the United States government via the COVID-19 Vaccines Global Access (COVAX) programme

KUALA
LUMPUR, MALAYSIA – Media OutReach -
5 July 2021 – DHL Express, the
world’s leading logistics provider, has successfully delivered the United
States government’s donation of the Pfizer-BioNTech vaccine today.

The arrival of around 1,000,000 doses comes as
part of a recent commitment by the U.S. to assist with recovery efforts
worldwide. This shipment is made possible via the COVAX global vaccine sharing
programme that aims to accelerate global equitable access to immunisation
against the pandemic.

“We are deeply honoured by the trust that our
customers have placed in us and I’m incredibly proud that the team has yet
again stepped up to successfully deliver another batch of COVID-19 vaccines to
Malaysia. As DHL Express continues to leverage our global network and strong
medical logistics expertise to ensure that these life-saving vaccines arrive
safely and promptly, we must also remind ourselves of the need for
collaboration amongst various parties and countries to manage this public
health crisis effectively,” said Ken Lee, CEO, DHL Express Asia Pacific.

DHL Express arranged for the collection of the
vaccines from facilities in the US before it was airlifted from our Cincinnati
Hub to the DHL Express Subang Gateway, where it would be distributed to
designated locations in Kuala Lumpur. From door-to-door, the journey spanned
only four days in complete compliance with stringent handling and storage
requirements.

“To date, DHL has transported more than 300
million doses of approved vaccines worldwide, five million of which were to
Malaysia,” said Julian Neo, Managing Director of DHL Express Malaysia and
Brunei. “The shipment today marks another milestone in combatting the spread of
COVID-19 and contributing to the country’s recovery. In keeping with our
mandate of connecting people and improving lives, we are proud to continue
playing an active role in seeking a safe, new normal for the businesses and
communities we serve.”

More than 9,000 life sciences and healthcare
specialists work across DHL’s dedicated global network so that pharmaceutical,
medical devices, clinical trials and research organisations, wholesalers and
distributors, as well as hospitals and healthcare providers are connected
across the value chain and through digitalisation, from clinical trials to
point of care, and every step in between.

DHL’s portfolio for the healthcare industry
includes 150+ pharmacists, 20+ clinical trials depots, 100+ certified stations,
160+ GDP-qualified warehouses, 15+ GMP-certified sites, 135+ medical express
sites, and a time-definite international express network covering over 220
countries and territories. On a global scale, logistics providers are
challenged to establish medical supply chain rapidly to deliver vaccines of
unprecedented amount of more than 10 billion doses worldwide—also in regions
with less developed logistics infrastructures, where approximately 3 billion
people live. To provide global coverage over the next two years, DHL estimated
in its vaccine logistics whitepaper that up to 200,000 pallet shippers and 15 million
cooling boxes as well as 15,000 flights will be required across the various
supply chain setups.